Search All UT System Experts

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

David C. Wheeler, Niels Jongs, Bergur V. Stefansson, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Anna Maria Langkilde, John J.V. McMurray, Peter Rossing, Michal Nowicki, István Wittmann, Ricardo Correa-Rotter, C. David Sjöström, Robert D. Toto, Hiddo J.L. Heerspink

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences